Literature DB >> 11322670

A pharmacy discharge plan for hospitalized elderly patients--a randomized controlled trial.

I Nazareth1, A Burton, S Shulman, P Smith, A Haines, H Timberal.   

Abstract

OBJECTIVES: to investigate the effectiveness of a pharmacy discharge plan in elderly hospitalized patients.
DESIGN: randomized controlled trial. SUBJECTS AND SETTINGS: we randomized patients aged 75 years and older on four or more medicines who had been discharged from three acute general and one long-stay hospital to a pharmacy intervention or usual care.
INTERVENTIONS: the hospital pharmacist developed discharge plans which gave details of medication and support required by the patient. A copy was given to the patient and to all relevant professionals and carers. This was followed by a domiciliary assessment by a community pharmacist. In the control group, patients were discharged from hospital following standard procedures that included a discharge letter to the general practitioner listing current medications. OUTCOMES: the primary outcome was re-admission to hospital within 6 months. Secondary outcomes included the number of deaths, attendance at hospital outpatient clinics and general practice and proportion of days in hospital over the follow-up period, together with patients' general well-being, satisfaction with the service and knowledge of and adherence to prescribed medication.
RESULTS: we recruited 362 patients, of whom 181 were randomized to each group. We collected hospital and general practice data on at least 91 and 72% of patients respectively at each follow-up point and interviewed between 43 and 90% of the study subjects. There were no significant differences between the groups in the proportion of patients re-admitted to hospital between baseline and 3 months or 3 and 6 months. There were no significant differences in any of the secondary outcomes.
CONCLUSIONS: we found no evidence to suggest that the co-ordinated hospital and community pharmacy care discharge plans in elderly patients in this study influence outcomes.

Entities:  

Mesh:

Year:  2001        PMID: 11322670     DOI: 10.1093/ageing/30.1.33

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  50 in total

Review 1.  Evidence-based strategies for the optimization of pharmacotherapy in older people.

Authors:  Eva Topinková; Jean Pierre Baeyens; Jean-Pierre Michel; Pierre-Olivier Lang
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

Review 2.  The role of the pharmacist in optimizing pharmacotherapy in older people.

Authors:  Anne Spinewine; Daniela Fialová; Stephen Byrne
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

Review 3.  Adherence to medicines in the older-aged with chronic conditions: does intervention by an allied health professional help?

Authors:  Sheila A Doggrell
Journal:  Drugs Aging       Date:  2010-03-01       Impact factor: 3.923

Review 4.  Improving Medication Adherence and Health Outcomes in Older Adults: An Evidence-Based Review of Randomized Controlled Trials.

Authors:  Zachary A Marcum; Joseph T Hanlon; Michael D Murray
Journal:  Drugs Aging       Date:  2017-03       Impact factor: 3.923

5.  Medication non-adherence among elderly patients newly discharged and receiving polypharmacy.

Authors:  L Pasina; A L Brucato; C Falcone; E Cucchi; A Bresciani; M Sottocorno; G C Taddei; M Casati; C Franchi; C D Djade; A Nobili
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

Review 6.  Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review.

Authors:  Marlies M E Geurts; Jaap Talsma; Jacobus R B J Brouwers; Johan J de Gier
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

7.  Drug-related problems and pharmacotherapeutic advisory intervention at a medicine clinic.

Authors:  Buster Mannheimer; Johanna Ulfvarson; Sara Eklöf; Monica Bergqvist; Eva Andersén-Karlsson; Hans Pettersson; Christer von Bahr
Journal:  Eur J Clin Pharmacol       Date:  2006-10-26       Impact factor: 2.953

8.  Impact of Clinical Pharmacist on the Pediatric Intensive Care Practice: An 11-Year Tertiary Center Experience.

Authors:  Sandeep Tripathi; Heidi M Crabtree; Karen R Fryer; Kevin K Graner; Grace M Arteaga
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jul-Aug

9.  Structure and markers of appropriateness, quality and performance of drug treatment over a 1-year period after hospital discharge in a cohort of elderly patients with cardiovascular diseases from Germany.

Authors:  Sebastian Harder; Philipp Fischer; Markus Krause-Schäfer; Klaus Ostermann; Gottfried Helms; Helge Prinz; Mike Hahmann; Horst Baas
Journal:  Eur J Clin Pharmacol       Date:  2004-12-01       Impact factor: 2.953

10.  Impact of pharmaceutical care on adherence, hospitalisations and mortality in elderly patients.

Authors:  Charlotte Olesen; Philipp Harbig; Kirsten Marie Buus; Ishay Barat; Else Marie Damsgaard
Journal:  Int J Clin Pharm       Date:  2013-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.